CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis
CHAPTER 4: SYNTHETIC DRUGS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By product
4.2. Enabling Products
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. DNA Synthesis
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Oligonucleotide Synthesis
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Enabled Products
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Pharmaceuticals
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Chemical
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Biofuels
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
4.9. Agriculture
4.9.1. Key Market Trends, Growth Factors and Opportunities
4.9.2. Market Size and Forecast, By Region
4.9.3. Market Share Analysis, By Country
4.10. Core Products
4.10.1. Key Market Trends, Growth Factors and Opportunities
4.10.2. Market Size and Forecast, By Region
4.10.3. Market Share Analysis, By Country
4.11. Synthetic DNA
4.11.1. Key Market Trends, Growth Factors and Opportunities
4.11.2. Market Size and Forecast, By Region
4.11.3. Market Share Analysis, By Country
4.12. Synthetic Genes
4.12.1. Key Market Trends, Growth Factors and Opportunities
4.12.2. Market Size and Forecast, By Region
4.12.3. Market Share Analysis, By Country
4.13. Synthetic Cells
4.13.1. Key Market Trends, Growth Factors and Opportunities
4.13.2. Market Size and Forecast, By Region
4.13.3. Market Share Analysis, By Country
4.14. XNA
4.14.1. Key Market Trends, Growth Factors and Opportunities
4.14.2. Market Size and Forecast, By Region
4.14.3. Market Share Analysis, By Country
4.15. Chassis Organisms
4.15.1. Key Market Trends, Growth Factors and Opportunities
4.15.2. Market Size and Forecast, By Region
4.15.3. Market Share Analysis, By Country
CHAPTER 5: SYNTHETIC DRUGS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Enabling Technology
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Genome Engineering
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Microfluidics Technologies
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. DNA Synthesis Sequencing Technologies
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Bioinformatics Technologies
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Biological Components And Integrated Systems Technologies
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
5.8. Enabled Technology,
5.8.1. Key Market Trends, Growth Factors and Opportunities
5.8.2. Market Size and Forecast, By Region
5.8.3. Market Share Analysis, By Country
5.9. Pathway Engineering,
5.9.1. Key Market Trends, Growth Factors and Opportunities
5.9.2. Market Size and Forecast, By Region
5.9.3. Market Share Analysis, By Country
5.10. Synthetic Microbial Consortia
5.10.1. Key Market Trends, Growth Factors and Opportunities
5.10.2. Market Size and Forecast, By Region
5.10.3. Market Share Analysis, By Country
5.11. Biofuels Technologies
5.11.1. Key Market Trends, Growth Factors and Opportunities
5.11.2. Market Size and Forecast, By Region
5.11.3. Market Share Analysis, By Country
CHAPTER 6: SYNTHETIC DRUGS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Research Development
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Chemicals
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Agriculture
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Pharmaceuticals Diagnostics
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Biofuels
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Environment
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Biotechnology
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
6.9. Biomaterials
6.9.1. Key Market Trends, Growth Factors and Opportunities
6.9.2. Market Size and Forecast, By Region
6.9.3. Market Share Analysis, By Country
6.10. Others
6.10.1. Key Market Trends, Growth Factors and Opportunities
6.10.2. Market Size and Forecast, By Region
6.10.3. Market Share Analysis, By Country
CHAPTER 7: SYNTHETIC DRUGS MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Hospitals
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinics
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Others
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
CHAPTER 8: SYNTHETIC DRUGS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By product
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Synthetic Drugs Market
8.2.7.1. Market Size and Forecast, By product
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Synthetic Drugs Market
8.2.8.1. Market Size and Forecast, By product
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Synthetic Drugs Market
8.2.9.1. Market Size and Forecast, By product
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By product
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Synthetic Drugs Market
8.3.7.1. Market Size and Forecast, By product
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Synthetic Drugs Market
8.3.8.1. Market Size and Forecast, By product
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Synthetic Drugs Market
8.3.9.1. Market Size and Forecast, By product
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Synthetic Drugs Market
8.3.10.1. Market Size and Forecast, By product
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Synthetic Drugs Market
8.3.11.1. Market Size and Forecast, By product
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Russia Synthetic Drugs Market
8.3.12.1. Market Size and Forecast, By product
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End User
8.3.13. Rest Of Europe Synthetic Drugs Market
8.3.13.1. Market Size and Forecast, By product
8.3.13.2. Market Size and Forecast, By Technology
8.3.13.3. Market Size and Forecast, By Application
8.3.13.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By product
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Synthetic Drugs Market
8.4.7.1. Market Size and Forecast, By product
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Synthetic Drugs Market
8.4.8.1. Market Size and Forecast, By product
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Synthetic Drugs Market
8.4.9.1. Market Size and Forecast, By product
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Synthetic Drugs Market
8.4.10.1. Market Size and Forecast, By product
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Synthetic Drugs Market
8.4.11.1. Market Size and Forecast, By product
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Thailand Synthetic Drugs Market
8.4.12.1. Market Size and Forecast, By product
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End User
8.4.13. Malaysia Synthetic Drugs Market
8.4.13.1. Market Size and Forecast, By product
8.4.13.2. Market Size and Forecast, By Technology
8.4.13.3. Market Size and Forecast, By Application
8.4.13.4. Market Size and Forecast, By End User
8.4.14. Indonesia Synthetic Drugs Market
8.4.14.1. Market Size and Forecast, By product
8.4.14.2. Market Size and Forecast, By Technology
8.4.14.3. Market Size and Forecast, By Application
8.4.14.4. Market Size and Forecast, By End User
8.4.15. Rest of Asia Pacific Synthetic Drugs Market
8.4.15.1. Market Size and Forecast, By product
8.4.15.2. Market Size and Forecast, By Technology
8.4.15.3. Market Size and Forecast, By Application
8.4.15.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By product
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Synthetic Drugs Market
8.5.7.1. Market Size and Forecast, By product
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Synthetic Drugs Market
8.5.8.1. Market Size and Forecast, By product
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Synthetic Drugs Market
8.5.9.1. Market Size and Forecast, By product
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End User
8.5.10. UAE Synthetic Drugs Market
8.5.10.1. Market Size and Forecast, By product
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End User
8.5.11. Argentina Synthetic Drugs Market
8.5.11.1. Market Size and Forecast, By product
8.5.11.2. Market Size and Forecast, By Technology
8.5.11.3. Market Size and Forecast, By Application
8.5.11.4. Market Size and Forecast, By End User
8.5.12. Rest of LAMEA Synthetic Drugs Market
8.5.12.1. Market Size and Forecast, By product
8.5.12.2. Market Size and Forecast, By Technology
8.5.12.3. Market Size and Forecast, By Application
8.5.12.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping Of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning,2022
CHAPTER 10: COMPANY PROFILES
10.1. Mylan N.V.
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. Noramco
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Lygos Inc.
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Hyasynth Biologicals, Inc.
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Alkem Labs
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Renew Biopharma
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. KBL Merger Corp. IV
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. Ginkgo Bioworks
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Emerald Health Pharmaceuticals
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. CB Therapeutics, Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
10.11. Insys Therapeutics, Inc.
10.11.1. Company Overview
10.11.2. Key Executives
10.11.3. Company Snapshot
10.11.4. Operating Business Segments
10.11.5. Product Portfolio
10.11.6. Business Performance
10.11.7. Key Strategic Moves and Developments
